How dangerous are India’s generic drugs? Very


India relies on the weak oversight of developing countries that make up the bulk of its exports – that’s how it can continue to push substandard and often deadly medicines there. — Bloomberg

FOR a nation that seeks to claim the mantle of “pharmacy to the world,” India is scandalously short on regulatory oversight.

In the last six months, its generic cough syrups have killed dozens of children, its eye drops have caused blindness and its chemotherapy drugs have been contaminated.

The Star Festive Promo: Get 35% OFF Digital Access

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
India , genericdrugs , regulation , oversight , scandals

Next In Business News

The parcel overhang
Zero abandoned homes�by�2030?
Unmasking housing market pricing abuses
Ringgit likely to trade cautiously next week ahead of key US data
Powering a new reinvestment cycle as demand surges
Up in Arms - or up the value chain?
Asia bonds for diversification
AI disruption fears rock markets
Private equity hits a sixer
Dubai luxe property keeps booming

Others Also Read